Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF
- 31 March 2005
- journal article
- case report
- Published by Elsevier in Journal of Clinical Virology
- Vol. 32 (3) , 241-244
- https://doi.org/10.1016/j.jcv.2004.05.020
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptaseAIDS, 2004
- Genotypic and Phenotypic Predictors of the Magnitude of Response to Tenofovir Disoproxil Fumarate Treatment in Antiretroviral‐Experienced PatientsThe Journal of Infectious Diseases, 2004
- Change to abacavir-lamivudine-tenofovir combination treatment in patients with HIV-1 who had complete virological suppressionThe Lancet, 2003
- Tenofovir Disoproxil Fumarate in Nucleoside-Resistant HIV-1 InfectionAnnals of Internal Medicine, 2003
- A Novel Genetic Pathway of Human Immunodeficiency Virus Type 1 Resistance to Stavudine Mediated by the K65R MutationJournal of Virology, 2003
- Extended Treatment With Tenofovir Disoproxil Fumarate in Treatment-Experienced HIV-1–Infected Patients: Genotypic, Phenotypic, and Rebound AnalysesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Comparison of Genotypic and Phenotypic Resistance Patterns of Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Stavudine and Didanosine or Zidovudine and LamivudineThe Journal of Infectious Diseases, 2001
- Human Immunodeficiency Virus Type 1 Expressing the Lamivudine‐Associated M184V Mutation in Reverse Transcriptase Shows Increased Susceptibility to Adefovir and Decreased Replication Capability In VitroThe Journal of Infectious Diseases, 1999
- Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.Proceedings of the National Academy of Sciences, 1995
- Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidineAntimicrobial Agents and Chemotherapy, 1994